These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 7617730

  • 1. Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice.
    Souilhac J, Poncelet M, Rinaldi-Carmona M, Le Fur G, Soubrié P.
    Pharmacol Biochem Behav; 1995 May; 51(1):3-7. PubMed ID: 7617730
    [Abstract] [Full Text] [Related]

  • 2. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
    Gifford AN, Samiian L, Gatley SJ, Ashby CR.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):187-92. PubMed ID: 9145770
    [Abstract] [Full Text] [Related]

  • 3. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR, Koek W.
    Eur J Pharmacol; 2007 Aug 13; 569(1-2):70-6. PubMed ID: 17553486
    [Abstract] [Full Text] [Related]

  • 4. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
    Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH.
    J Pharmacol Exp Ther; 1998 Aug 13; 286(2):697-703. PubMed ID: 9694923
    [Abstract] [Full Text] [Related]

  • 5. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L, Cossu G, Martellotta CM, Fratta W.
    Psychopharmacology (Berl); 2001 Aug 13; 156(4):410-6. PubMed ID: 11498718
    [Abstract] [Full Text] [Related]

  • 6. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F.
    Eur J Pharmacol; 1999 Nov 12; 384(1):37-42. PubMed ID: 10611417
    [Abstract] [Full Text] [Related]

  • 7. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C.
    Eur J Neurosci; 1999 Feb 12; 11(2):691-9. PubMed ID: 10051770
    [Abstract] [Full Text] [Related]

  • 8. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
    Mendiguren A, Pineda J.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):83-8. PubMed ID: 16483566
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
    Pertwee RG, Griffin G, Lainton JA, Huffman JW.
    Eur J Pharmacol; 1995 Sep 25; 284(3):241-7. PubMed ID: 8666005
    [Abstract] [Full Text] [Related]

  • 10. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R.
    Eur J Pharmacol; 2003 Feb 07; 461(1):27-34. PubMed ID: 12568912
    [Abstract] [Full Text] [Related]

  • 11. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR.
    Psychopharmacology (Berl); 2006 Oct 07; 188(3):306-14. PubMed ID: 16953389
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoid modulation of intestinal propulsion in mice.
    Colombo G, Agabio R, Lobina C, Reali R, Gessa GL.
    Eur J Pharmacol; 1998 Feb 26; 344(1):67-9. PubMed ID: 9570450
    [Abstract] [Full Text] [Related]

  • 13. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR.
    J Pharmacol Exp Ther; 2006 Dec 26; 319(3):1211-8. PubMed ID: 16943255
    [Abstract] [Full Text] [Related]

  • 14. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
    Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L.
    Eur J Pharmacol; 2002 Aug 16; 450(1):77-83. PubMed ID: 12176112
    [Abstract] [Full Text] [Related]

  • 15. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
    Maneuf YP, Crossman AR, Brotchie JM.
    Exp Neurol; 1997 Nov 16; 148(1):265-70. PubMed ID: 9398468
    [Abstract] [Full Text] [Related]

  • 16. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM, Paria BC, Dey SK.
    Biol Reprod; 1996 Oct 16; 55(4):756-61. PubMed ID: 8879486
    [Abstract] [Full Text] [Related]

  • 17. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway.
    Anderson LA, Anderson JJ, Chase TN, Walters JR.
    Brain Res; 1995 Sep 11; 691(1-2):106-14. PubMed ID: 8590042
    [Abstract] [Full Text] [Related]

  • 18. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
    Rawls SM, Cabassa J, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2002 Jun 11; 301(3):963-8. PubMed ID: 12023525
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
    Coutts AA, Pertwee RG.
    Br J Pharmacol; 1997 Aug 11; 121(8):1557-66. PubMed ID: 9283688
    [Abstract] [Full Text] [Related]

  • 20. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
    Kathmann M, Weber B, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan 11; 363(1):50-6. PubMed ID: 11191836
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.